PolarityTE Inc., a Salt Lake City-based commercial-stage biotechnology company, has announced the addition of Minnie Baylor-Henry to the company’s board of directors. Baylor-Henry is a regulatory affairs leader who served for nearly a decade at the U.S. Food and Drug Administration (FDA) before spending most of her career at Johnson & Johnson, where she served in multiple roles, most recently as worldwide vice president of regulatory affairs. While at the FDA, she served as regulatory review officer; director/branch chief at the Division of Drug Marketing, Advertising and Communications; and national health fraud coordinator at the FDA Office of Regulatory Affairs. She also was the national director for regulatory, risk and compliance for the life science division at Deloitte. She currently operates her own consulting firm, providing strategic regulatory affairs advice to pharmaceutical, biopharmaceutical and medical device companies.